{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Balance+Assessment&page=6", "query": { "condition": "Balance Assessment", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 243, "total_pages": 25, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Balance+Assessment&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Balance+Assessment&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T11:59:05.720Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00430456", "title": "Treadmill Exercise Prescriptions to Improve Fitness Versus Ambulatory Function After Stroke.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Exercise", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 120, "start_date": "2006-08", "completion_date": "2012-06", "has_results": false, "last_update_posted_date": "2012-06-12", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00430456" }, { "nct_id": "NCT06886269", "title": "A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "14C-VX-993", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 8, "start_date": "2025-03-21", "completion_date": "2025-05-17", "has_results": false, "last_update_posted_date": "2025-06-18", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06886269" }, { "nct_id": "NCT02178865", "title": "Predicting Normal vs. Carrier Status in Euploid Embryos of Translocation Carriers", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Balanced Chromosomal Translocation" ], "interventions": [], "intervention_types": [], "sponsor": "Reproductive Medicine Associates of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 11, "start_date": "2014-06", "completion_date": "2017-02", "has_results": false, "last_update_posted_date": "2017-03-17", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Basking Ridge, New Jersey", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02178865" }, { "nct_id": "NCT01180738", "title": "Body Weight Supported Treadmill Training vs. Overground Walking Training in Persons With Chronic Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stroke", "Difficulty Walking" ], "interventions": [ { "name": "Body weight supported treadmill training", "type": "BEHAVIORAL" }, { "name": "Overground walking training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stephanie Miller", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2010-08", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2020-04-02", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01180738" }, { "nct_id": "NCT02126514", "title": "A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Mass Balance Study" ], "interventions": [ { "name": "AZD3293", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 12, "start_date": "2014-05", "completion_date": "2014-05", "has_results": false, "last_update_posted_date": "2014-06-16", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02126514" }, { "nct_id": "NCT04234672", "title": "A Study to Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "TAK-831 Oral Tablet", "type": "DRUG" }, { "name": "[14C]TAK-831 IV Infusion", "type": "DRUG" }, { "name": "[14C]TAK-831 Oral Suspension", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "19 Years to 55 Years · Male only" }, "enrollment_count": 6, "start_date": "2020-02-17", "completion_date": "2020-04-04", "has_results": true, "last_update_posted_date": "2021-06-30", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04234672" }, { "nct_id": "NCT07221266", "title": "Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease (PD)" ], "interventions": [ { "name": "Guided Cycling", "type": "BEHAVIORAL" }, { "name": "Non-Contact Boxing", "type": "BEHAVIORAL" }, { "name": "Traditional Physical Therapy Program (Standard of Care)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Texas, El Paso", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 45, "start_date": "2026-04-21", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 2, "location_summary": "El Paso, Texas", "locations": [ { "city": "El Paso", "state": "Texas" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07221266" }, { "nct_id": "NCT01702194", "title": "TD-1211 IV/Oral Mass Balance Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "OIC" ], "interventions": [ { "name": "TD-1211 IV [C14]", "type": "DRUG" }, { "name": "TD-1211 PO [C14]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glycyx Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 10, "start_date": "2012-11", "completion_date": "2013-03", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01702194" }, { "nct_id": "NCT04637139", "title": "A Study to Evaluate the Mass Balance Absorption and AME of VBR", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Hepatitis B" ], "interventions": [ { "name": "Vebicorvir (VBR)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Assembly Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 6, "start_date": "2020-12-01", "completion_date": "2020-12-22", "has_results": false, "last_update_posted_date": "2021-01-12", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04637139" }, { "nct_id": "NCT03811834", "title": "A Study to Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Mobocertinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Millennium Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "19 Years to 55 Years · Male only" }, "enrollment_count": 7, "start_date": "2019-01-22", "completion_date": "2019-03-11", "has_results": true, "last_update_posted_date": "2024-02-12", "last_synced_at": "2026-10-29T11:59:05.720Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03811834" } ] }